April 30, 2014 — OTTAWA, ON — Competition Bureau
The Competition Bureau has published the highlights of its one-day workshop on antitrust issues in the pharmaceutical sector, which was held in Ottawa on November 13, 2013.
The workshop examined certain strategies and practices used by pharmaceutical firms, in Canada and abroad, that may lead to diminished competition between branded and generic pharmaceuticals. The event brought together representatives from the Bureau, Health Canada, the US Federal Trade Commission, the legal community and the pharmaceutical sector, as well as other stakeholders. Participants discussed a number of ongoing competition law issues that the sector faces, such as "pay for delay" or "reverse payment" settlements and the life cycle management strategies employed by drug patent holders.
The main goal of the workshop was to gather information that will inform the Bureau’s position on these and other issues in the pharmaceutical sector going forward.
For media enquiries, please contact:
For general enquiries, please contact:
Toll free: 1‑800‑348‑5358
TTY (hearing impaired): 1‑866‑694‑8389
The Competition Bureau, as an independent law enforcement agency, ensures that Canadian businesses and consumers prosper in a competitive and innovative marketplace.